CHROMOSOME BREAKAGE INDUCED BY BLEOMYCIN IN AN ATAXIA TELANGIECTASIA LYMPHOBLASTOID LINE - CORRELATION WITH FRAGILE SITES AND EPSTEIN-BARR-VIRUS DNA LOCALIZATION

被引:6
作者
CAPOROSSI, D
TEDESCHI, B
VERNOLE, P
PORFIRIO, B
NICOLETTI, B
机构
来源
CYTOGENETICS AND CELL GENETICS | 1989年 / 52卷 / 3-4期
关键词
D O I
10.1159/000132873
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
引用
收藏
页码:180 / 185
页数:6
相关论文
共 41 条
[1]   REPORT OF THE COMMITTEE ON STRUCTURAL CHROMOSOME CHANGES IN NEOPLASIA [J].
BLOOMFIELD, CD ;
TRENT, JM ;
VANDENBERGHE, H .
CYTOGENETICS AND CELL GENETICS, 1987, 46 (1-4) :344-366
[2]  
BRIDGES BA, 1982, ATAXIA TELANGIECTASI
[3]   REGIONAL CHROMOSOME LOCALIZATION OF HUMAN PAPILLOMAVIRUS INTEGRATION SITES NEAR FRAGILE SITES, ONCOGENES, AND CANCER CHROMOSOME BREAKPOINTS [J].
CANNIZZARO, LA ;
DURST, M ;
MENDEZ, MJ ;
HECHT, BK ;
HECHT, F .
CANCER GENETICS AND CYTOGENETICS, 1988, 33 (01) :93-98
[4]   SPECIFIC SITES FOR EBV ASSOCIATION IN THE NAMALWA BURKITT-LYMPHOMA CELL-LINE AND IN A LYMPHOBLASTOID LINE TRANSFORMED INVITRO WITH EBV [J].
CAPOROSSI, D ;
VERNOLE, P ;
PORFIRIO, B ;
TEDESCHI, B ;
FREZZA, D ;
NICOLETTI, B ;
CALEF, E .
CYTOGENETICS AND CELL GENETICS, 1988, 48 (04) :220-223
[5]   HERPES-SIMPLEX VIRUS GENE-PRODUCTS INVOLVED IN THE INDUCTION OF CHROMOSOMAL-ABERRATIONS [J].
CHENETMONTE, C ;
MOHAMMAD, F ;
CELLUZZI, CM ;
SCHAFFER, PA ;
FARBER, FE .
VIRUS RESEARCH, 1986, 6 (03) :245-260
[6]  
DANDREA AD, 1978, P NATL ACAD SCI USA, V75, P5608
[7]  
DURNAM D, 1986, CANCER CELL, V4, P349
[8]   PAPILLOMAVIRUS SEQUENCES INTEGRATE NEAR CELLULAR ONCOGENES IN SOME CERVICAL CARCINOMAS [J].
DURST, M ;
CROCE, CM ;
GISSMANN, L ;
SCHWARZ, E ;
HUEBNER, K .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (04) :1070-1074
[9]  
FERGUSONSMITH MA, 1984, CLIN LAB, V4, P297
[10]   EFFECT OF CAFFEINE IN-G2 ON X-RAY-INDUCED CHROMOSOMAL-ABERRATIONS AND MITOTIC INHIBITION IN ATAXIA TELANGIECTASIA FIBROBLAST AND LYMPHOBLASTOID-CELLS [J].
HANSSON, K ;
NATARAJAN, AT ;
KIHLMAN, BA .
HUMAN GENETICS, 1984, 67 (03) :329-335